PATH
Menu

This report describes use of the Uniject™ device prefilled with 10 international units (IU) of oxytocin for actively managing the third stage of labor in selected health centers in Mali. Although this single-dose, autodisable injection device has previously been used for tetanus toxoid vaccination in Mali, the Ministry of Health lacked documentation of the safety and feasibility of using the device to deliver oxytocin for active management of the third stage of labor (AMTSL).

Author(s): Prevention of Postpartum Hemorrhage Initiative (POPPHI)

Corporate author(s): PATH

Publication date: December 2008

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA